Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Estrogen can temporarily slow down hair growth but this can be reversed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

The side gland of Suncus murinus is a good model for studying human sebaceous glands.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Chromosomal differences affect how muscle cells respond to testosterone.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hair loss in women may have causes other than hormones.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.